-
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
Increasing Diversity in Clinical TrialsResearchers share approaches for improving participation among underrepresented groups at AACR conference.
by Thomas Celona
-
Fixing Systems, Building TrustThe AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.
by Eric Fitzsimmons
-
From the Editor-in-Chief
Immunotherapy Gets PersonalTherapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
-
Forward Look
The Promise of Liquid BiopsiesBlood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
by Tara Haelle
-
Forward Look
Should Race Inform Screening Recommendations?Study suggests incorporating race and ethnicity in age-based breast cancer screening guidelines.
by Darcy Lewis
-
Forward Look
Diaphragm DisturbancesHiccups are a common and underreported side effect of some cancer treatments.
by Carolyn Bernhardt
-
Immunotherapy: When Is Sooner Better Than Later?Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
-
Living With Chronic Blood CancerThanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Facts and Stats
Will We Make the Moonshot?As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
